These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
460 related items for PubMed ID: 9649303
1. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Gelasco A, Lippard SJ. Biochemistry; 1998 Jun 30; 37(26):9230-9. PubMed ID: 9649303 [Abstract] [Full Text] [Related]
2. DNA oligonucleotide duplexes containing intramolecular platinated cross-links: energetics, hydration, sequence, and ionic effects. Kankia BI, Soto AM, Burns N, Shikiya R, Tung CS, Marky LA. Biopolymers; 2002 Nov 05; 65(3):218-27. PubMed ID: 12228927 [Abstract] [Full Text] [Related]
3. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent. Baruah H, Wright MW, Bierbach U. Biochemistry; 2005 Apr 26; 44(16):6059-70. PubMed ID: 15835895 [Abstract] [Full Text] [Related]
4. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove. Cosman M, Hingerty BE, Luneva N, Amin S, Geacintov NE, Broyde S, Patel DJ. Biochemistry; 1996 Jul 30; 35(30):9850-63. PubMed ID: 8703959 [Abstract] [Full Text] [Related]
5. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA. Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ. J Mol Biol; 2000 Feb 25; 296(3):803-12. PubMed ID: 10677282 [Abstract] [Full Text] [Related]
6. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Kaspárková J, Mellish KJ, Qu Y, Brabec V, Farrell N. Biochemistry; 1996 Dec 24; 35(51):16705-13. PubMed ID: 8988007 [Abstract] [Full Text] [Related]
7. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ. Nature; 1995 Oct 19; 377(6550):649-52. PubMed ID: 7566180 [Abstract] [Full Text] [Related]
8. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization. Suo Z, Lippard SJ, Johnson KA. Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812 [Abstract] [Full Text] [Related]
9. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ. Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126 [Abstract] [Full Text] [Related]
10. Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations. Téletchéa S, Skauge T, Sletten E, Kozelka J. Chemistry; 2009 Nov 16; 15(45):12320-37. PubMed ID: 19813235 [Abstract] [Full Text] [Related]
11. NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex. Wu Y, Pradhan P, Havener J, Boysen G, Swenberg JA, Campbell SL, Chaney SG. J Mol Biol; 2004 Aug 27; 341(5):1251-69. PubMed ID: 15321720 [Abstract] [Full Text] [Related]
12. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues. Saad JS, Natile G, Marzilli LG. J Am Chem Soc; 2009 Sep 02; 131(34):12314-24. PubMed ID: 19655752 [Abstract] [Full Text] [Related]
13. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J, Novakova O, Farrell N, Brabec V. Biochemistry; 2003 Jan 28; 42(3):792-800. PubMed ID: 12534292 [Abstract] [Full Text] [Related]
14. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts. Beljanski V, Villanueva JM, Doetsch PW, Natile G, Marzilli LG. J Am Chem Soc; 2005 Nov 16; 127(45):15833-42. PubMed ID: 16277526 [Abstract] [Full Text] [Related]
15. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II). Chifotides HT, Koshlap KM, Pérez LM, Dunbar KR. J Am Chem Soc; 2003 Sep 03; 125(35):10714-24. PubMed ID: 12940757 [Abstract] [Full Text] [Related]
16. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. Spingler B, Whittington DA, Lippard SJ. Inorg Chem; 2001 Oct 22; 40(22):5596-602. PubMed ID: 11599959 [Abstract] [Full Text] [Related]
17. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Kane SA, Lippard SJ. Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559 [Abstract] [Full Text] [Related]
18. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B. Met Ions Biol Syst; 1996 Feb 20; 33():105-41. PubMed ID: 8742842 [Abstract] [Full Text] [Related]
19. Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG). Chifotides HT, Dunbar KR. Chemistry; 2006 Aug 25; 12(25):6458-68. PubMed ID: 16900545 [Abstract] [Full Text] [Related]
20. NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II). Paquet F, Pérez C, Leng M, Lancelot G, Malinge JM. J Biomol Struct Dyn; 1996 Aug 25; 14(1):67-77. PubMed ID: 8877563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]